ISRCTN46112469已完成未知
A comparative pharmacokinetic study: 5 Fluorouracil (5FU) provided as patient specific individual doses and as standard doses according to a 'dose banding' principle
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 26
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- Female
入选标准
- •Women with breast cancer who are receiving adjuvant therapy.
排除标准
- •Patients on reduced doses of FEC chemotherapy, with known liver metastases, who have received chemotherapy for previous malignancies.
研究者
相似试验
招募中
2 期
Effectiveness of 5% fluorouracil ointment in the treatment of genital wartsGenital wart.Viral wartsIRCT20230913059421N1Ahvaz University of Medical Sciences60
尚未招募
不适用
Injection of 5-fluorouracil in treatment of keloidsCTRI/2020/03/024219ok Nayak Hospital and associated MAMC
进行中（未招募）
不适用
5-Fluorouracil in relapsed EpendymomaRecurrent or refractory ependymomaMedDRA version: 17.1Level: PTClassification code 10014967Term: EpendymomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2014-001470-34-GBRoyal Marsden NHS Foundation Trust
已完成
2 期
Randomized phase II/III study of 5-fluorouracil /l-leucovorin vs. 5-fluorouracil /l-leucovorin plus paclitaxel in gastric cancer with severe peritoneal metastasis (JCOG1108/WJOG7312G, abbreviation:GC_FL/FLTAX_P2/3)Gastric cancerJPRN-UMIN000010949Japan Clinical Oncology Group (JCOG)330
已完成
不适用
Phase II randomized trial comparing 5-fluorouracil in continuous infusion and cisplatin (FP) versus leucovorin, bolus 5-fluorouracil and cisplatin (FLP) in metastatic gastric, pancreatic and oesophageal cancerMetastatic gastric, pancreatic and oesophageal cancerOesophagealCancerISRCTN05842222French Federation of Digestive Cancers (Fédération Francophone de la Cancérologie Digestive [FFCD]) (France)232